Arvind Nath Scientist ‘E’, National Institute of Malaria Research, Dwarka, New Delhi 110077, India
Address for correspondence: Arvind Nath, Scientist ‘E’, National Institute of Malaria Research, Dwarka, New Delhi 110077, India E-mail: natha.hq@icmr.gov.in
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
Arvind Nath/Prevention of Malaria/Indian J Prev Med. 2022;10(1):23-25.
Timeline
Received : February 16, 2022
Accepted : March 16, 2022
Published : June 30, 2022
Abstract
NA
References
1. American Public Health Association. Malaria. In Control of Communicable Diseases Manual 20th Edition, Washington D.C., U.S.A. 2016. Information as of 26 August 2021. Available at https://ccdm.aphapublications.org/doi/epdf/10.2105/CCDM.2745.097 Accessed on 11 February 2022.
2. World Health Organization. International Travel and Health. Situation as of 1 January 2012. Updates 2019. Geneva. Available athttps://www.who.int/publications/i/item/9789241580472 Accessed on 14 February 2022.
3. World Health Organization. 2021 News. Geneva. Available at https://www.who.int/ news/item/06-10-2021-who-recommendsgroundbreaking-malaria-vaccine-for-childrenat-risk/Accessed on 13 October 2021.
4. Vandoolaeghe P. and Schuerman L. 2016. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. Expert Rev. Vaccines2016 Dec;15(12):1481-1493.DOI: 10.1080/14760584.2016.1236689. Available at https://pubmed.ncbi.nlm.nih.gov/27841689/Accessed on 13 October 2021.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Arvind Nath/Prevention of Malaria/Indian J Prev Med. 2022;10(1):23-25.
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.